Investor Relations
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jan 2, 2020CoSara tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus recently granted regulatory approval by CDSCO to formally launch at India Diagnostic Expo
-
Dec 10, 2019Vector Smart™ NAM-e multiplex PCR test to provide proactive defense against mosquito populations carrying the deadly eastern equine encephalitis virus
-
Dec 3, 2019CoSara Saragene™ tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus now available for sale and distribution as in vitro diagnostics
-
Nov 13, 2019Revenue includes sales of infectious disease, mosquito abatement products and AgBio primer design services
-
Oct 29, 2019Company completes sale and installation to one of the largest private molecular diagnostics labs in Ghana
-
Oct 15, 2019Vector Smart™ products being presented at 6 vector control conferences in October to prepare for 2020 mosquito season
-
Oct 10, 2019Vector Smart™ ZDC multiplex PCR test to aid prevention of tropical disease proliferation in the US and abroad
-
Sep 19, 2019Company will host booth to introduce and promote mosquito abatement products to midwestern states in Tulsa, OK on Sept 19-20
-
Sep 4, 2019Expansion to include increased royalties and cover additional applications for Company’s technology platform
-
Aug 21, 2019Event to include demos and training for distributors and end-users of Company’s products
-
Aug 14, 2019Q2 revenue reflects increase over Q1, as US sales of mosquito abatement products and AgBio primer design services gain momentum
-
Aug 1, 2019Company’s booth will promote infectious disease products and technology applications for NGS, liquid biopsy, and SNP differentiation
-
Apr 30, 2019Method includes proprietary, single-step closed-tube NGS library prep in 3 hours or less